A step toward a universal flu vaccine
With computer models and lab experiments, researchers are working on a strategy for vaccines that could protect against any influenza virus.
Three from MIT receive National Health Institute Awards
Michael Birnbaum, Anders Hansen, and Tami Lieberman receive NIH Director’s New Innovator Awards from the NIH Common Fund’s High-Risk, High-Reward Research program.
3 Questions: Why getting ahead of Covid-19 requires modeling more than a health crisis
Researchers urge a holistic approach to forecasting the virus’ impact on public health and the economy.
MIT chapter of the Phi Beta Kappa Society inducts 115 students from the Class of 2020
Remarkably large cohort of graduating seniors honored for excellence in the liberal arts.
Turning diamond into metal
Normally an insulator, diamond becomes a metallic conductor when subjected to large strain in a new theoretical model.
Nanoparticles can turn off genes in bone marrow cells
Using these new particles, researchers could develop treatments for heart disease and other conditions.
How we make moral decisions
In some situations, asking “what if everyone did that?” is a common strategy for judging whether an action is right or wrong.
A champion of renewable energy
MIT senior Darya Guettler advocates for climate action and broader deployment of zero-carbon energy sources.
Helping companies navigate Covid-19
Professor Yossi Sheffi's latest book, “The New (Ab)Normal,” offers a key supply chain perspective on the pandemic.
Cancer researchers collaborate, target DNA damage repair pathways for cancer therapy
MIT researchers find blocking the expressions of the genes XPA and MK2 enhances the tumor-shrinking effects of platinum-based chemotherapies in p53-mutated cancers.